Surgiphor Us in TSA
Launched by ROTHMAN INSTITUTE ORTHOPAEDICS · Sep 16, 2024
Trial Information
Current as of September 08, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The purpose of this study is to determine the rate of reduction of positive cultures collected before and after wound irrigation with either Surgiphor or sterile normal saline during primary total shoulder arthroplasty
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults age \>18 years
- • Participants undergoing elective primary total shoulder arthroplasty
- • Participants willing to provide written consent
- Exclusion Criteria:
- • History of prior surgery to the operative shoulder
- • Known allergy to povidone iodine, iodine or shellfish
- • active clinical infection
- • participation in other clinical trials
About Rothman Institute Orthopaedics
Rothman Institute Orthopaedics is a leading healthcare organization specializing in orthopedic care and research. With a commitment to advancing the field of orthopedics, Rothman Institute conducts innovative clinical trials aimed at improving patient outcomes and enhancing treatment methodologies. Renowned for its team of highly skilled orthopedic surgeons and researchers, the institute integrates cutting-edge technology and evidence-based practices to deliver exceptional care. Through its rigorous research initiatives, Rothman Institute is dedicated to fostering advancements in orthopedic medicine and contributing to the overall improvement of musculoskeletal health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported